Argolyn Bioscience Grows Management Team

PhotoPhoto

Back to: News Release
Dr. Nick Ellis, an industry veteran with almost 30 years of biopharmaceutical experience, has been named President & CEO of Argolyn Bioscience, a company developing novel drugs to treat psychosis, pain and other disorders. (Photo: Business Wire)
Dr. Nick Ellis, an industry veteran with almost 30 years of biopharmaceutical experience, has been named President & CEO of Argolyn Bioscience, a company developing novel drugs to treat psychosis, pain and other disorders. (Photo: Business Wire)

Download Formats

Share This Photo

URL:

Smart Multimedia Gallery

Dr. Nick Ellis, an industry veteran with almost 30 years of biopharmaceutical experience, has been named President & CEO of Argolyn Bioscience, a company developing novel drugs to treat psychosis, pain and other disorders. (Photo: Business Wire)
Dr. Nick Ellis, an industry veteran with almost 30 years of biopharmaceutical experience, has been named President & CEO of Argolyn Bioscience, a company developing novel drugs to treat psychosis, pain and other disorders. (Photo: Business Wire)Photo

Dr. Nick Ellis, an industry veteran with almost 30 years of biopharmaceutical experience, has been named President & CEO of Argolyn Bioscience, a company developing novel drugs to treat psychosis, pain and other disorders. (Photo: Business Wire)

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.